These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 39159176)

  • 1. Drug-induced QT interval prolongation in patients with heart failure with preserved ejection fraction.
    Huang CY; Overholser BR; Sowinski KM; Jaynes HA; Kovacs RJ; Tisdale JE
    PLoS One; 2024; 19(8):e0308999. PubMed ID: 39159176
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of Sotalol and Dofetilide Dosing at a Large Academic Medical Center.
    Ting C; Malloy R; Knowles D
    J Cardiovasc Pharmacol Ther; 2020 Sep; 25(5):438-443. PubMed ID: 32347108
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk prediction for adverse events during initiation of sotalol and dofetilide for the treatment of atrial fibrillation.
    Agusala K; Oesterle A; Kulkarni C; Caprio T; Subacius H; Passman R
    Pacing Clin Electrophysiol; 2015 Apr; 38(4):490-8. PubMed ID: 25626340
    [TBL] [Abstract][Full Text] [Related]  

  • 4. QT variability during initial exposure to sotalol: experience based on a large electronic medical record.
    Weeke P; Delaney J; Mosley JD; Wells Q; Van Driest S; Norris K; Kucera G; Stubblefield T; Roden DM
    Europace; 2013 Dec; 15(12):1791-7. PubMed ID: 23787903
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potentially modifiable factors of dofetilide-associated risk of torsades de pointes among hospitalized patients with atrial fibrillation.
    Naksuk N; Sugrue AM; Padmanabhan D; Kella D; DeSimone CV; Kapa S; Asirvatham SJ; Lee HC; Ackerman MJ; Noseworthy PA
    J Interv Card Electrophysiol; 2019 Mar; 54(2):189-196. PubMed ID: 30353374
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of QT Interval Readings in Normal Sinus Rhythm Between a Smartphone Heart Monitor and a 12-Lead ECG for Healthy Volunteers and Inpatients Receiving Sotalol or Dofetilide.
    Garabelli P; Stavrakis S; Albert M; Koomson E; Parwani P; Chohan J; Smith L; Albert D; Xie R; Xie Q; Reynolds D; Po S
    J Cardiovasc Electrophysiol; 2016 Jul; 27(7):827-32. PubMed ID: 27027653
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Magnitude of increase in QTc interval after initiation of dofetilide in patients with persistent atrial fibrillation is associated with increased rates of pharmacological cardioversion and long-term freedom from recurrent atrial fibrillation.
    Huang HD; Waks JW; Steinhaus DA; Zimetbaum P
    Heart Rhythm; 2016 Jul; 13(7):1410-7. PubMed ID: 26921760
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of Oral Contraceptives With Drug-Induced QT Interval Prolongation in Healthy Nonmenopausal Women.
    Salem JE; Dureau P; Bachelot A; Germain M; Voiriot P; Lebourgeois B; Trégouët DA; Hulot JS; Funck-Brentano C
    JAMA Cardiol; 2018 Sep; 3(9):877-882. PubMed ID: 30073300
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dofetilide-induced long QT and torsades de pointes.
    Aktas MK; Shah AH; Akiyama T
    Ann Noninvasive Electrocardiol; 2007 Jul; 12(3):197-202. PubMed ID: 17617063
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atrial Fibrillation in Heart Failure With Preserved, Mid-Range, and Reduced Ejection Fraction.
    Sartipy U; Dahlström U; Fu M; Lund LH
    JACC Heart Fail; 2017 Aug; 5(8):565-574. PubMed ID: 28711451
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dofetilide-Associated QT Prolongation: Total Body Weight Versus Adjusted or Ideal Body Weight for Dosing.
    Wang SY; Welch TD; Sangha RS; Maloney RW; Cui Z; Kaplan AV
    J Cardiovasc Pharmacol; 2018 Sep; 72(3):161-165. PubMed ID: 29985283
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of the effect of a single oral dose of telithromycin on sotalol-induced qt interval prolongation in healthy women.
    Démolis JL; Strabach S; Vacheron F; Funck-Brentano C
    Br J Clin Pharmacol; 2005 Aug; 60(2):120-7. PubMed ID: 16042664
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Electrocardiographic Predictors of Torsadogenic Risk During Dofetilide or Sotalol Initiation: Utility of a Novel T Wave Analysis Program.
    Sugrue A; Kremen V; Qiang B; Sheldon SH; DeSimone CV; Sapir Y; Striemer BL; Brady P; Asirvatham SJ; Ackerman MJ; Friedman P; Noseworthy PA
    Cardiovasc Drugs Ther; 2015; 29(5):433-41. PubMed ID: 26411977
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of reverse use-dependent blocking actions of class III antiarrhythmic drugs by 24-hour Holter electrocardiography.
    Okada Y; Ogawa S; Sadanaga T; Mitamura H
    J Am Coll Cardiol; 1996 Jan; 27(1):84-9. PubMed ID: 8522715
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Are women more susceptible than men to drug-induced QT prolongation? Concentration-QTc modelling in a phase 1 study with oral rac-sotalol.
    Darpo B; Karnad DR; Badilini F; Florian J; Garnett CE; Kothari S; Panicker GK; Sarapa N
    Br J Clin Pharmacol; 2014 Mar; 77(3):522-31. PubMed ID: 23819796
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase IV trial evaluating the effectiveness and safety of dofetilide.
    Guanzon AV; Crouch MA
    Ann Pharmacother; 2004; 38(7-8):1142-7. PubMed ID: 15161945
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced Response to Drug-Induced QT Interval Lengthening in Patients with Heart Failure with Preserved Ejection Fraction.
    Tisdale JE; Jaynes HA; Overholser BR; Sowinski KM; Fisch MD; Rodgers JE; Aldemerdash A; Hsu CC; Wang N; Muensterman ET; Rao VU; Kovacs RJ
    J Card Fail; 2020 Sep; 26(9):781-785. PubMed ID: 32592895
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An evaluation of the impact of oral magnesium lactate on the corrected QT interval of patients receiving sotalol or dofetilide to prevent atrial or ventricular tachyarrhythmia recurrence.
    McBride BF; Min B; Kluger J; Guertin D; Henyan NN; Coleman CI; Silver BB; White CM
    Ann Noninvasive Electrocardiol; 2006 Apr; 11(2):163-9. PubMed ID: 16630091
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atrial fibrillation and risk of adverse outcomes in heart failure with reduced, mildly reduced, and preserved ejection fraction: A systematic review and meta-analysis.
    Kroshian G; Joseph J; Kinlay S; Peralta AO; Hoffmeister PS; Singh JP; Yuyun MF
    J Cardiovasc Electrophysiol; 2024 Apr; 35(4):715-726. PubMed ID: 38348517
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Causes and Temporal Patterns of 30-Day Readmission Among Older Adults Hospitalized With Heart Failure With Preserved or Reduced Ejection Fraction.
    Goyal P; Loop M; Chen L; Brown TM; Durant RW; Safford MM; Levitan EB
    J Am Heart Assoc; 2018 Apr; 7(9):. PubMed ID: 29686028
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.